Agios Pharmaceuticals AGIO
NASDAQ AGIO
$31.80 -0.68 (-2.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Agios Pharmaceuticals (AGIO) Non Operating Investment Income (2021 - 2024)

Updated

Agios Pharmaceuticals' Non Operating Investment Income was $200 million in FY2024.

Analysis

Agios Pharmaceuticals (AGIO) Non Operating Investment Income (2021 - 2024) Analysis & Trends

  • Non Operating Investment Income shows a three-year compound annual growth rate of 211.2% (FY2021 to FY2024).
  • The FY2024 figure marks the lowest annual Non Operating Investment Income since FY2021.
  • Per Business Quant data, Non Operating Investment Income in earlier years was $6.64 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Agios Pharmaceuticals 1.90 Bn 1.90 Bn 41.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 200.00 Mn
Dec 31, 2022 -9.90 Mn
Sep 30, 2022 4.44 Mn
Jun 30, 2022 2.70 Mn
Mar 31, 2022 2.70 Mn
Dec 31, 2021 2.64 Mn
Sep 30, 2021 2.00 Mn
Jun 30, 2021 2.00 Mn
API Access

Agios Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=AGIO&period=max&api_key=YOUR_API_KEY